MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-24-2026
Medtronic PLC General and Administrative Expenses 2011-2026 | MDT
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Medtronic PLC
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 B | 10.7 B | 10.4 B | 10.3 B | 10.1 B | 9.88 B | 10.2 B | 9.95 B | 10 B | 9.47 B | 6.9 B | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 10.8 B | 6.9 B | 9.9 B |
Quarterly General and Administrative Expenses Medtronic PLC
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.96 B | 2.96 B | 2.81 B | - | 2.72 B | 2.76 B | 2.66 B | - | 2.67 B | 2.69 B | 2.61 B | - | 2.62 B | 2.62 B | 2.57 B | - | 2.54 B | 2.62 B | 5.16 B | - | 2.59 B | 2.6 B | 2.6 B | 2.42 B | 2.6 B | 2.62 B | 2.62 B | 2.54 B | 2.52 B | 2.6 B | 2.6 B | 2.6 B | 2.39 B | 2.54 B | 2.44 B | 2.48 B | 2.32 B | 2.42 B | 2.42 B | 2.43 B | 1.49 B | 2.34 B | 2.34 B | 2.45 B | - | 1.51 B | 1.51 B | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.16 B | 1.49 B | 2.56 B |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B |  USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.36 | 0.37 % | $ 21.9 M | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
LENSAR
LNSR
|
26.5 M | $ 5.6 | -7.74 % | $ 64.5 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 32.7 | 2.98 % | $ 1.51 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 37.03 | 1.09 % | $ 1.15 B | USA |
 |
Orthofix Medical
OFIX
|
554 M | $ 11.86 | -0.13 % | $ 470 M |  Curacao |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
39.3 M | $ 24.73 | 0.98 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
35 M | $ 0.73 | 7.63 % | $ 39.7 M | USA |
 |
Aethlon Medical
AEMD
|
3.24 M | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
Penumbra
PEN
|
663 M | $ 335.02 | -0.17 % | $ 13 B | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 11.65 | 12.34 % | $ 1.57 B | USA |
 |
Myomo
MYO
|
14 M | $ 0.69 | -2.28 % | $ 28.9 M | USA |
 |
Insulet Corporation
PODD
|
1.16 B | $ 226.85 | -0.1 % | $ 16 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
22.5 M | $ 2.36 | -3.28 % | $ 138 M | Israel |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |
 |
Profound Medical Corp.
PROF
|
10.3 M | $ 5.14 | -4.76 % | $ 180 M | Canada |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.92 | 4.96 % | $ 146 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.0 | -2.88 % | $ 375 M | USA |
 |
Outset Medical
OM
|
37.9 M | $ 3.55 | -1.94 % | $ 54 K | USA |
 |
Quanterix Corporation
QTRX
|
138 M | $ 3.76 | -4.57 % | $ 160 M | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 52.18 | -0.06 % | $ 1.53 B | USA |
 |
Pulmonx Corporation
LUNG
|
101 M | $ 1.33 | -4.32 % | $ 54.1 M | USA |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Sintx Technologies
SINT
|
6.2 M | $ 2.57 | 0.78 % | $ 7.13 M | USA |
 |
InspireMD
NSPR
|
20.7 M | $ 1.79 | 2.87 % | $ 115 M | Israel |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
634 M | - | - | $ 2.07 B | USA |
 |
Second Sight Medical Products
EYES
|
806 K | - | -0.97 % | $ 54.4 M | USA |